These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6482577)

  • 1. [D-penicillamine therapy in rheumatoid arthritis: adverse reactions with 2 different administration regimens].
    Fernández Dapica P; Peña J; Merino J; Casanueva B; Morillas L; Mateo I; Rodríguez-Valverde V; Gómez-Reino J
    Med Clin (Barc); 1984 Jun; 83(5):184-7. PubMed ID: 6482577
    [No Abstract]   [Full Text] [Related]  

  • 2. [D-penicillamine--a current review of areas of use and dosage guidelines].
    Sörensen H
    Z Rheumatol; 1988; 47 Suppl 1():13-6. PubMed ID: 3063002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent treatment with D-penicillamine is effective in lower doses and with fewer adverse effects in patients with rheumatoid arthritis.
    Hakoda M; Taniguchi A; Kamatani N; Akahoshi T; Kashiwazaki S
    J Rheumatol; 1994 Sep; 21(9):1637-41. PubMed ID: 7799341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of the efficacy of 2 different doses of D-penicillamine in rheumatoid arthritis].
    Agababova E; Sidel'nikova S; Aseeva E; Nikol'skaia N; Gaziian R
    Ter Arkh; 1981; 53(7):62-7. PubMed ID: 6457408
    [No Abstract]   [Full Text] [Related]  

  • 5. Proteinuria in D-penicillamine-treated rheumatoid arthritis.
    Crawhall JC
    J Rheumatol Suppl; 1981; 7():161-3. PubMed ID: 6939879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholestasis associated with d-penicillamine therapy for rheumatoid arthritis.
    McLeod BD; Kinsella TD
    Can Med Assoc J; 1979 Apr; 120(8):965-6. PubMed ID: 436073
    [No Abstract]   [Full Text] [Related]  

  • 7. Penicillamine in rheumatoid arthritis.
    Hill AG; Hill HF
    Agents Actions Suppl; 1979; (5):129-38. PubMed ID: 393102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [5-year treatment of rheumatoid polyarthritis with D-penicillamine].
    Duquesnoy B; Cocheteux P; Siame JL; Delcambre B
    Sem Hop; 1983 May; 59(21):1641-4. PubMed ID: 6310780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic studies of D-penicillamine in the treatment of rheumatoid arthritis.
    Payne RW; Cahill CL
    J Okla State Med Assoc; 1969 Oct; 62(10):487-91. PubMed ID: 5406880
    [No Abstract]   [Full Text] [Related]  

  • 10. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3 years of penicillamine D therapy of 100 patients with rheumatoid polyarthritis].
    Santamaria A; Ruíz de La Torre R; Barceló P; Ripoll M; Escarpenter J; Barceló P
    Rev Esp Reum Enferm Osteoartic; 1977; 20(4):335-8. PubMed ID: 341244
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term results of D-penicillamine treatment in rheumatoid arthritis].
    Kutsuna T; Maeda K; Okamoto T
    Ryumachi; 1986 Aug; 26(4):270-7. PubMed ID: 3563727
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adverse effects of D-penicillamine in rheumatoid arthritis with reference to prior gold therapy].
    Ishihara Y; Fujita A; Ohdoi S; Saitoh K; Katsube S; Azuma T
    Ryumachi; 1985 Feb; 25(1):15-9. PubMed ID: 4002060
    [No Abstract]   [Full Text] [Related]  

  • 14. [The basal therapy of rheumatoid arthritis with d-penicillamine (author's transl)].
    Waskönig FW; Meyer W
    Munch Med Wochenschr; 1973 Nov; 115(45):2047-50. PubMed ID: 4801138
    [No Abstract]   [Full Text] [Related]  

  • 15. Hazards of penicillamine therapy in the treatment of rheumatoid arthritis.
    Day AT; Golding JR
    Postgrad Med J; 1974 Aug; 50 Suppl 2():71-3. PubMed ID: 4467184
    [No Abstract]   [Full Text] [Related]  

  • 16. [Late results of the D-penicillamine treatment of rheumatoid arthritis].
    Agababova ER; Sidel'nikova SM; Aseeva EM; Nikol'skaia NV; Gaziian RA
    Vopr Revm; 1981; (2):25-7. PubMed ID: 7034367
    [No Abstract]   [Full Text] [Related]  

  • 17. Selected adverse reactions of D-penicillamine.
    Stein HB; Chalmers A; Schroeder ML; Dillon A
    Clin Invest Med; 1984; 7(1):73-6. PubMed ID: 6723128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Initiation of myasthentic reactions by means of d-penicillamine (author's transl1].
    Rosenberger K; Winter H; Adams AE
    Nervenarzt; 1978 May; 49(5):277-81. PubMed ID: 673084
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse effects of D-penicillamine in rheumatoid arthritis.
    Stein HB; Patterson AC; Offer RC; Atkins CJ; Teufel A; Robinson HS
    Ann Intern Med; 1980 Jan; 92(1):24-9. PubMed ID: 7350870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current status of D-penicillamine therapy in chronic polyarthritis].
    Franke M; Menning H; Ströbel G
    Z Rheumatol; 1981; 40(2):54-61. PubMed ID: 7282106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.